Squarepoint’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,600
Closed -$202K 4459
2025
Q4
$202K Sell
4,600
-1,800
-28% -$74.5K ﹤0.01% 3871
2025
Q3
$264K Buy
+6,400
New +$257K ﹤0.01% 3770
2025
Q2
Sell
-42,000
Closed -$1.55M 4651
2025
Q1
$1.55M Buy
42,000
+21,600
+106% +$770K ﹤0.01% 2300
2024
Q4
$679K Buy
+20,400
New +$662K ﹤0.01% 3449

Other funds holding EXEL

Squarepoint's EXEL Position: Q1 2026 in Review

Squarepoint reduced its Exelixis (EXEL) stake by 93% in Q1 2026, selling an estimated $16M and leaving 27,072 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #2648.

Squarepoint first reported a position in EXEL in Q4 2015 and has held it in 37 quarters since. The position peaked at $17.5M in Q4 2025. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • Squarepoint held 27,072 shares of Exelixis worth $1.16M as of Q1 2026.
  • Squarepoint sold 371,153 Exelixis shares in Q1 2026, an estimated $16M.
  • Exelixis made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2648 holding.
  • Squarepoint first reported a position in Exelixis in Q4 2015 and has held it in 37 quarters since.
  • Squarepoint's Exelixis position peaked at $17.5M in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.